Dengue fever, a mosquito-borne viral infection, poses a significant global health concern. Dengue antibodies play a crucial role in understanding and diagnosing this disease. These antibodies are proteins produced by the immune system in response to the dengue virus. They serve as essential tools for detecting and monitoring the infection. Dengue NS1 antibodies utilized in rapid tests, CMIA, ELISA, and other applications are provided for manufacturers of rapid test kits.

• Several dozens of research and technical experts have successively established world-class technical platforms, including prokaryotic cell expression, eukaryotic cell expression, baculovirus expression, monoclonal/polyclonal expression, antibody recombinant expression, and nanobody technology.
• These platforms have served as the foundation for the development and production of hundreds of varieties of biologically active proteins. These proteins cover a wide range of series including infectious diseases, vector-borne diseases, respiratory diseases, inflammatory conditions, cancer marker, zoonotic diseases, and animal (pets/livestock) disease screening.
• This extensive range ensures the application of common immunodiagnostic products, all developed and produced using these cutting-edge platforms.